Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member, COO
2023-07-31–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Cannabist Co Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get CBSTQ alertsDavid Hart is recorded as CEO at Cannabist Co Holdings Inc. (CBSTQ) since January 15, 2024, Board Member at Cannabist Co Holdings Inc. (CBSTQ) since January 1, 2024 and COO at Cannabist Co Holdings Inc. (CBSTQ) since July 31, 2023. The newest filing on record that lists David Hart as Board Member at Cannabist Co Holdings Inc. (CBSTQ) is dated September 3, 2025. Cannabist Co Holdings Inc. reported in an 8-K filed January 19, 2024 that David Hart was appointed Chief Executive Officer, effective January 15, 2024. Cannabist Co Holdings Inc. reported in an 8-K filed August 3, 2023 that David Hart was appointed President and Chief Operating Officer, effective July 31, 2023. David Hart has spoken on 2 earnings calls across 1 company, most recently for Cannabist Co Holdings Inc. on November 10, 2025. Cannabist Co Holdings Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Cannabist Co Holdings Inc. includes Michael Abbott (Chairman and Board Member), James A.C. Kennedy (Board Member), Jeff Clarke (Board Member) and 6 others.
“On January 15, 2024, David Hart was appointed Chief Executive Officer of the Company.”
“On July 31, 2023, the Company appointed David Hart, 46, as President and Chief Operating Officer of the Company.”
“During the third quarter, we remained focused on driving efficiencies, continued cost containment, liquidity, and balance sheet management.”
“As we consider the results of the first half of 2025, our priorities remain unchanged. We are focused on liquidity and balance sheet management while continuing to make operational improvements, including taking costs out of our business.”
2024-01-15–present
2024-01-01–present
Last confirmed September 3, 2025
2023-07-31–present
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member, COO
2023-07-31–present